King Wealth Management Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

King Wealth Management Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$548K	–	191
2021 Q3	$548K	Hold	5,000	–	–	0.11%	95
2021 Q2	$468K	Sell	5,000 -1,000	-17%	-$92K	0.1%	103
2021 Q1	$552K	Sell	6,000 -2,700	-31%	-$228K	0.12%	85
2020 Q4	$636K	Sell	8,700 -3,300	-28%	-$245K	0.15%	80
2020 Q3	$932K	Buy	12,000 +5,000	+71%	+$344K	0.24%	60
2020 Q2	$389K	Hold	7,000	–	–	0.11%	94
2020 Q1	$207K	Buy	+7,000	New	+$237K	0.09%	123
2019 Q3	–	Sell	-9,000	Closed	-$217K	–	148
2019 Q2	$217K	Buy	+9,000	New	+$228K	0.06%	126

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

King Wealth Management Group's HZNP Position: Q4 2021 in Review

King Wealth Management Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 5,000 shares — an estimated $548K sold.

King Wealth Management Group first reported a position in HZNP in Q2 2019 and held it in 8 quarters. The position peaked at $932K in Q3 2020. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

King Wealth Management Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
King Wealth Management Group sold 5,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $548K.
King Wealth Management Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 8 quarters.
King Wealth Management Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $932K in Q3 2020.
611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on King Wealth Management Group's 13F filing for Q4 2021, filed 11 Feb 2022.